Skip to content

OptiMalVax

An EC Horizon 2020 Project
Menu
  • Home
    • Home Page
  • Background
    • Malaria Parasite Lifecycle
    • Global Malaria Burden
  • Approach
    • OptiMalVax Objectives
    • OptiMalVax Strategy
    • OptiMalVax Project Chart
    • OptiMalVax Organisation
    • Pre-Erythrocytic Malaria Vaccines
    • Blood-Stage Malaria Vaccines
    • Transmission Blocking Malaria Vaccines
    • Virus-like Particles
    • Collaborators
  • Home Page
  • Background
    • Global Malaria Burden
    • Malaria Parasite Lifecycle
  • Approach
    • OptiMalVax Objectives
    • OptiMalVax Strategy
    • OptiMalVax Organisation
    • OptiMalVax Project Chart
    • Pre-Erythrocytic Malaria Vaccines
    • Blood-Stage Malaria Vaccines
    • Transmission Blocking Malaria Vaccines
    • Virus-like Particles
  • Collaborators
  • News

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733273
Built with Make. Your friendly small business site builder.